Introduction
The PBD binds to a phosphoserine/threonine-containing motif, which stimulates harboring individual point mutations in the kinase domain and the PBD. We also expressed 100 several truncation mutants of TbPLK to investigate the requirement of the PBD for TbPLK 101 localization. Moreover, we examined the potential intramolecular interaction between the kinase 102 domain and the PBD of TbPLK as well as the potential formation of an intermolecular TbPLK 103 homodimer mediated by the association between the PBDs and/or between the kinase domains. 104
Finally, we tested whether the PBD of TbPLK is involved in binding to TbPLK substrates. Our 105 results suggest that the PBD is necessary, but not sufficient for TbPLK localization, and that it is 106 not involved in direct substrate binding. The PBD in TbPLK appears to be implicated in 107 regulating TbPLK activity through intramolecular association with the kinase domain to inhibit 108 its activity. 109
110

Results
111
The kinase activity is essential for TbPLK function, but not for TbPLK localization to the FAZ 112
To investigate the structure-function relationship of TbPLK, we employed a method that 113 couples RNAi-mediated gene silencing with ectopic expression of TbPLK mutant in the same 114 cell line (Supplemental Fig. 1A, B) . To avoid interfering with the ectopically expressed TbPLK 115 mutants, we first tested whether RNAi against the 3'-UTR of TbPLK is sufficient to knock down 116 the expression of TbPLK. A 549-bp DNA fragment immediately downstream of TbPLK coding 117 region was cloned into a modified RNAi vector, pZJM-PAC, and the resulting construct was 118 introduced into 29-13 cell line (Wirtz et al., 1999) . Northern blot showed that about 95% of 119
TbPLK mRNA was depleted from the cells after RNAi induction for 2 days, and this led to a 120 significant growth arrest (Supplemental Fig. 2A ). Flow cytometry analysis showed an 121 accumulation of cells with 4C DNA content after RNAi induction for 2 days and then the 122 emergence of cells with 8C DNA content after RNAi for 3 days (Supplemental Fig. 2B ). 123
Moreover, upon RNAi induction, cells with two nuclei and one kinetoplast (2N1K) and cells 124 with multiple nuclei were significantly increased (Supplemental Fig. 2C To determine whether TbPLK deficiency caused by RNAi against TbPLK 3'-UTR can be 129 rescued by ectopic expression of wild-type TbPLK, we transfected pZJM-TbPLK-UTR-PAC cell 130 line with pLew100-TbPLK-3HA-Phleo, and induced RNAi and ectopic expression of TbPLK by 131 tetracycline. In vitro kinase assays showed that the ectopically expressed TbPLK-3HA was 132 active (Fig. 1A) , and immunofluorescence assays showed that TbPLK-3HA was correctly 133 localized (Fig. 1B) . Further, Western blot showed that TbPLK-3HA was expressed, and RT-PCR 134 confirmed that the endogenous TbPLK mRNA was depleted (Fig. 1C, right panel) , consistent 135 with the Northern blot (Supplemental Fig. 2A, inset) . We found that ectopic expression of wild-136 type TbPLK alleviated the growth defect of the TbPLK-UTR RNAi cell line (Fig. 1C , green line 137 versus purple line), suggesting that ectopic expression of TbPLK was able to complement the 138 RNAi mutant. It also suggests that epitope-tagging at the C-terminus of TbPLK does not 139 interfere with TbPLK function and localization. This agrees with the previous report that tagging 140 of a triple HA epitope at either the N-terminus or the C-terminus of TbPLK does not affect 141
TbPLK localization (Umeyama and Wang, 2008). However, in contrast to wild-type TbPLK, 142 ectopic expression of TbPLK-K70R, a kinase-dead TbPLK mutant (Fig. 1A) , was unable to 143 rescue the growth defect of the RNAi mutant (Fig. 1D , green line) despite that it was correctly 144 localized (Fig. 1B) . This result further confirmed that RNAi against the 3'-UTR of TbPLK was 145 specific. 146
We also overexpressed 3HA-tagged TbPLK and K70R mutant in wild-type 29-13 cell line 147 (Supplemental Fig. 1C type 29-13 cell line did not affect cell growth (Fig. 1D , red line) despite that it was correctly 154 targeted (data not shown), suggesting the lack of any dominant-negative effect for TbPLK-K70R. 155
Since the 29-13 cells expressing wild-type TbPLK and the TbPLK-UTR RNAi cells 156 expressing TbPLK-K70R have growth defect, we compared the phenotypic differences between 157 them. Upon tetracycline induction, cells with two nuclei and one kinetoplast (2N1K) appeared 158 and then decreased, which was followed by gradual increase of cells with multiple nuclei and 159 one kinetoplast (XN1K) in both cell lines (Fig. 1E) . Similarly, number of 2N2K cells was also 160 increased and then decreased, and this was followed by gradual increase of XN2K cells. There 161 was a slight enrichment of cells with multiple nuclei and multiple kinetoplasts (XNXK), but zoid 162 (0N1K) cells were not increased (Fig. 1E) . The increase of 2N1K cells in both cell lines suggests 163 the inhibition of kinetoplast segregation, which was likely due to the defect in basal body 164 duplication/segregation (Fig. 1F and data not shown) . Moreover, we found that TbPLK-UTR 165 RNAi/TbPLK-K70R OE cells accumulated multiple Golgi bodies (Fig. 1G) , which resembles the 166 defect caused by TbPLK RNAi (de Graffenried et al., 2008) . 167
168
Phosphorylation in the T-loop is crucial for TbPLK function, but not for TbPLK localization 169
It is known that human Plk1 is activated by Aurora A-mediated phosphorylation on Thr210 170 in the T-loop (Seki et al., 2008b) . Additionally, Thr214 in Plk1 is also phosphorylated in vivo, 171 but it is not known whether this is required for Plk1 activation (Dulla et al., 2010). TbPLK also 172 possesses the two conserved threonine residues, Thr198 and Thr202, in its T-loop ( Fig. 2A) , but 173 it is unclear whether they are phosphorylated and whether phosphorylation of them contributes to 174
TbPLK activation. To test this, we mutated Thr198 and Thr202 to alanine or aspartic acid, 175 respectively, and expressed each of the four mutant proteins in TbPLK-UTR RNAi cell line. In 176 vitro kinase assays showed that mutation of either residue to alanine disrupted their ability to 177 phosphorylate TbCentrin2, an in vitro substrate of TbPLK (de Graffenried et al., 2008), but 178 mutation to aspartic acid restored the kinase activity that was several-fold higher than the wild-179 type TbPLK (Fig. 2B ), indicating that phosphorylation of both threonine residues is required for 180
TbPLK activation. 181
Immunofluorescence assays showed that all four mutant proteins were localized correctly 182 to the anterior tip of the new FAZ (Fig. 2C) , suggesting that phosphorylation of TbPLK on 183 Thr198 and Thr202 is not necessary for TbPLK localization. When the two inactive mutants 184
were each expressed in TbPLK-UTR RNAi cells, cell growth was still arrested. However, when 185 the two phosphomimic mutants were each expressed in the same RNAi cell line, cell growth was 186 restored (Fig. 2D, green lines) . Although the two phosphomimic mutants are more active than 187 the wild-type TbPLK, the protein level of the two mutants is significantly lower than that of the 188 wild-type, and therefore, the overall kinase activity of the two mutants is similar to that of wild-189 type TbPLK (Fig. 2B) TbPLK-T202D, led to significant growth defect (Fig. 2D ) and inhibited kinetoplast segregation 201 and cytokinesis (Supplemental Fig. 3 ), similar to TbPLK overexpression in 29-13 cell line ( We mutated Trp557 to phenylalanine and Phe561, His710, and Lys712 to alanine, 232 respectively, and expressed them in TbPLK-UTR RNAi cells. In vitro kinase assays showed that 233 mutation of any of the four residues did not affect kinase activity (Fig. 3A) . Immunostaining 234 with anti-HA antibody showed that each of the four mutants was correctly localized to the 235 anterior tip of the new FAZ (Fig. 3B) , suggesting that mutation of these residues does not 236 abrogate TbPLK localization. Importantly, ectopic expression of the four TbPLK mutants in 237
TbPLK-UTR RNAi cells restored cell growth at a rate similar to the uninduced controls ( to examine whether human Plk1 is able to be correctly targeted in trypanosomes, 3HA-tagged 255
Plk1 was ectopically expressed in T. brucei. We found that Plk1-3HA was distributed throughout 256 the cytoplasm in all cell types ( 
The PBD of TbPLK is required, but not sufficient for TbPLK localization 262
Despite lacking the four key residues in the PBD of TbPLK (Supplemental Fig. 4A ), the 263 PBD may still be involved in targeting TbPLK to the anterior tip of the new FAZ. To test this, 264
we deleted the entire PBD from TbPLK and expressed the truncation mutant in T. brucei (Fig.  265   5A, B) . Surprisingly, overexpression of the PBD-deletion mutant resulted in severe growth 266 defect (Fig. 5C) , and the mutant protein was predominantly localized to the nucleus (Fig. 5D) , in 267 striking contrast to the overexpressed wild-type TbPLK, which was localized to the anterior tip 268 of the new FAZ as well as the anterior tip of the cell (Fig. 5D) (Fig. 5A ). To investigate whether this NLS is 278 responsible for nuclear localization of the PBD-deletion mutant, we further deleted the NLS 279 sequence. Like the PBD-deletion mutant, overexpression of the NLS-PBD-deletion mutant also 280 led to significant growth inhibition (Fig. 5C ). But this mutant protein was distributed in the 281 cytoplasm (Fig. 5D ), indicating that nuclear localization of the PBD-deletion mutant attributes to 282 this NLS. To test whether mutation of this NLS affects TbPLK function, we expressed TbPLK 283 mutant with all the arginine and lysine residues in the NLS mutated to alanine in TbPLK-UTR 284
RNAi cells and found that the NLS mutant was still able to complement the RNAi mutant (data 285 not shown), suggesting that the small fraction of TbPLK in the nucleus, if any, is likely not 286 essential for mitosis and cell proliferation. Together, these results suggest that the PBD is 287 necessary for TbPLK localization. 288
To further examine whether both Polo boxes are required for TbPLK localization, we 289 deleted the second Polo box (PB2) (Fig. 5A) . Overexpression of the PB2-deletion mutant also 290 caused growth inhibition, but the growth defect is less severe than that caused by overexpression 291 of the PBD-deletion mutant and the NLS-PBD-deletion mutant (Fig. 5C ), presumably due to the 292 lower expression level of the PB2-deletion mutant in the cell (Fig. 5B) . Surprisingly, the PB2-293 deletion mutant was also distributed to the cytoplasm (Fig. 5D) , suggesting that the presence of 294
Polo box 1 (PB1) downstream of the NLS may prevent its exposure to the nuclear targeting 295 machinery and consequently abolish its nuclear localization. It also suggests that correct 296 targeting of TbPLK requires the entire PBD. Finally, to test whether the PBD itself is sufficient 297 for localization, we expressed the PBD alone in trypanosomes (Fig. 5A, B) . Unlike the other 298 three truncation mutants, overexpression of the PBD did not inhibit cell growth (Fig. 5C) , and 299 the PBD was spread throughout the cytoplasm (Fig. 5D ). This contrasts to the localization of the 300 PBD of yeast and metazoan Plks, which is virtually identical to that of the endogenous Plks 301 TbCentrin2 was able to bring down wild-type TbPLK, TbPLK-K70R, and the KD, but not the 318 PBD (Fig. 6A) . We then tested the interaction between TbPLK and p110, another substrate of 319 TbPLK (our unpublished data), by GST pull-down, and we found that p110 was also capable of 320 precipitating the KD, but not the PBD, from the cell lysate (Fig. 6B) . Finally, to test whether 321 phosphorylated TbCentrin2 is able to bind to the PBD, GST pull-down was performed to 322 precipitate TbCentrin2 expressed in trypanosome cells. We found that the KD, but not the PBD, 323 was able to pull down phosphorylated TbCentin2 (Fig. 6C) . When the cell lysate was treated 324
with Lambda protein phosphatase (λPPase), the KD was still able to bring down the 325 dephosphorylated TbCentrin2 (Fig. 6C) . It should be noted that the GST-PBD exhibited weak 326 interaction with both phosphorylated and dephosphorylated TbCentrin2, but since the GST 327 control also showed non-specific binding to TbCentrin2, the weak association between GST-328 PBD and TbCentrin2 could attribute to non-specific binding (Fig. 6C) TbPLK appears to be different from that of other Plks (see above), which raised the interesting 338 question of whether it can bind to the KD and inhibits TbPLK activity. Through yeast two-hybrid 339 assays, we found that the PBD and the KD of TbPLK do interact, but both domains are also 340 capable of interacting with themselves in yeasts (Fig. 7A) . Additionally, the kinase-dead mutant, 341
TbPLK-K70R, but not the wild-type TbPLK, also interacts with itself in yeasts (Fig. 7A) . 342
To confirm these interactions, GST pull-down was carried out. Unlike in yeast cells where 343
TbPLK exhibits weak interactions with the KD and the PBD (Fig. 7A) , TbPLK was able to bring 344 down wild-type and kinase-dead TbPLKs, the KD, and the PBD from trypanosome lysate (Fig.  345   7B) . Similarly, the KD was also capable of pulling down all four proteins, whereas the PBD only 346 precipitated the KD and the PBD from the lysate (Fig. 7B) . Collectively, these results suggest 347 that TbPLK is capable of forming an intermolecular dimer through interactions between the KDs 348 or between the PBDs or between the KD and the PBD. However, the interaction between the KD 349 and the PBD detected by both yeast two-hybrid and GST pull-down suggests a potential 350 intramolecular association between the two domains. significantly inhibited by the PBD (Fig. 7C) . In contrast, the activity of TbPLK-T198D, the 356 phosphomimic mutant, was not affected by the PBD (Fig. 7C) . These results suggest that the 357 PBD plays an essential role in inhibiting the activity of TbPLK, and that this inhibition is 358 relieved when Thr198 in the activation loop is phosphorylated. 359 Discussion 360
In this paper, we investigated the structure-function relationship of TbPLK by ectopically 361 expressing various TbPLK mutants in trypanosome cells that are deficient in endogenous TbPLK. 362
This allowed us to identify a few residues essential for TbPLK function (Figs. 1 and 2 ). It also 363 enabled us to examine the requirement of those potentially important residues for TbPLK 364 localization (Figs. 1, 2, and 3) . Although there is the concern about the potential off-target effect 365 as well as the possible effect on the expression of the immediate downstream gene when 366 performing RNAi against the 3'-UTR of TbPLK, we found that the deficiency caused by RNAi 367 of TbPLK 3'-UTR can be readily complemented by ectopic expression of wild-type TbPLK, but 368 not the kinase-dead TbPLK (Fig. 1) Phosphorylation of another threonine residue in the activation loop of TbPLK, Thr202, 394 appears to be also required for TbPLK activation (Fig. 2) . However, like Thr198, the 395 corresponding protein kinase remains to be identified. It is known that phopshorylation of a 396 conserved serine residue, Ser137 in human Plk1 and Ser128 in Xenopus Plx1, also confers kinase 397 the PBD. However, we found that the kinase domain of TbPLK, but not the PBD, binds to its 415 substrates, TbCentrin2 and p110 (Fig. 6A, B) . Moreover, both the phosphorylated and 416 dephosphorylated TbCentrin2 interact with the kinase domain, but not the PBD (Fig. 6C) , 417
suggesting that interaction of TbPLK with TbCentrin2 does not require priming phosphorylation 418 of TbCentrin2. Since TbCentrin2 and p110 are the only known TbPLK substrates, it remains 419 unknown whether other substrates of TbPLK also bind to the kinase domain of TbPLK. 420
Nevertheless, our findings argue that the PBD is not necessarily required for substrate binding, at 421 least for TbCentrin2 and p110. This conclusion is further supported by the absence in the PBD of 422
TbPLK of the equivalent residues of Trp414, Leu490, His538, and Lys540 in human Plk1 PBD 423 (Supplemental Fig. 4) , all of which make direct contact with phosphopeptides and are each 424 and Lys712 in the PBD of TbPLK did not impair the localization of TbPLK (Fig. 3) , thus ruling 427 out any possibilities that these residues may compensate the absence of the equivalent residues of 428 Trp414, His538, and Lys540 in TbPLK. However, it should be noted that Drosophila Polo 429 kinase has been show to interact with its substrate, Map205, without priming phosphorylation of 430 Map205, and that the PBD, although required, was not sufficient for this interaction 431 (Archambault et al., 2008) . Additionally, the yeast Polo-like kinase homolog, Cdc5, was found to 432 bind to Dbf4 via a PBD surface distinct from that used to bind phosphoproteins (Chen and 433
Weinreich, 2010). These observations suggest that Plks appear to interact with their substrates by 434 more than one mechanism in other systems, and that some or one of these mechanisms may be 435 conserved with TbPLK. 436
Despite lacking direct involvement in substrate binding, the PBD of TbPLK apparently 437 regulates the activity of TbPLK by binding to its kinase domain and inhibiting its activity (Fig.  438 7), indicating a conserved role of the PBD in regulating PLK activity. The inhibition through 439
PBD-binding to the kinase domain is relieved when TbPLK is activated by phosphorylation of 440
Thr198 in the activation loop (Fig. 7C) 
